PLI scheme for pharma to benefit 55 firms, says Centre

The first category included biopharmaceuticals, complex generic drugs, patented drugs or drugs nearing patent expiry, cell-based or gene therapy drugs, orphan drugs, special empty capsules like HPMC, pullulan, enteric etc., complex excipients, and phytopharmaceuticals.


via Economictimes

No comments